Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Subcutaneous tanezumab 2.5 MG or 5 MG for patients with osteoarthritis of the knee or hip: onset and maintenance of efficacy over 24 weeks
  1. Home
  2. Publications
  3. Subcutaneous tanezumab 2.5 MG or 5 MG for patients with osteoarthritis of the knee or hip: onset and maintenance of efficacy over 24 weeks

Subcutaneous tanezumab 2.5 MG or 5 MG for patients with osteoarthritis of the knee or hip: onset and maintenance of efficacy over 24 weeks

Authors:
  • FBF. Berenbaum
    F. Berenbaum
  • RLR. Langford
    R. Langford
  • SPS. Perrot
    S. Perrot
  • KMK. Miki
    K. Miki
  • FBF.J. Blanco
    F.J. Blanco
  • NIN. Isogawa
    N. Isogawa
  • RJR. Junor
    R. Junor
  • LVL. Viktrup
    L. Viktrup
  • CWC.R. West
    C.R. West

Publisher website
Google Scholar
  • 1 April 2020
    • journal article
    • Published by Elsevier in Osteoarthritis and Cartilage
    • Vol. 28, S144-S145
    • DOI:10.1016/j.joca.2020.02.239
Abstract
No abstract available
Keywords
  • WOMAC
  • CLINICAL ENDPOINT
  • DISCONTINUATION
  • KNEE PAIN
Cited by 2 articles
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.